Untch M, von Minckwitz G, Gerber B, Schem C, et al. Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44). J Clin Oncol 2018 Mar 15:JCO2017759175. doi: 10.1200/JCO.2017.75.9175.
PMID: 29543566